BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22719943)

  • 1. Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure.
    Nibourg GA; Chamuleau RA; van der Hoeven TV; Maas MA; Ruiter AF; Lamers WH; Oude Elferink RP; van Gulik TM; Hoekstra R
    PLoS One; 2012; 7(6):e38778. PubMed ID: 22719943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor.
    Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1860-8. PubMed ID: 23770120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-bioartificial liver.
    Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
    Liver Int; 2013 Apr; 33(4):516-24. PubMed ID: 23387413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HepaRG-Progenitor Cell Derived Hepatocytes Cultured in Bioartificial Livers Are Protected from Healthy- and Acute Liver Failure-Plasma Induced Toxicity.
    van Wenum M; Treskes P; Adam AAA; van der Mark VA; Jongejan A; Moerland PD; van Gulik TM; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
    Cell Physiol Biochem; 2018; 48(5):2189-2204. PubMed ID: 30110678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 1 and phase 2 drug metabolism and bile acid production of HepaRG cells in a bioartificial liver in absence of dimethyl sulfoxide.
    Hoekstra R; Nibourg GA; van der Hoeven TV; Plomer G; Seppen J; Ackermans MT; Camus S; Kulik W; van Gulik TM; Elferink RP; Chamuleau RA
    Drug Metab Dispos; 2013 Mar; 41(3):562-7. PubMed ID: 23238784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines.
    van Wenum M; Adam AA; Hakvoort TB; Hendriks EJ; Shevchenko V; van Gulik TM; Chamuleau RA; Hoekstra R
    Int J Biol Sci; 2016; 12(8):964-78. PubMed ID: 27489500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of rat acute-liver-failure plasma on HepaRG cells.
    Hoekstra R; Nibourg GA; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Oude Elferink RP; Chamuleau RA
    Int J Artif Organs; 2012 Nov; 35(11):1006-14. PubMed ID: 23065880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HepaRG cell line is suitable for bioartificial liver application.
    Hoekstra R; Nibourg GA; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Lamers WH; Elferink RP; Chamuleau RA
    Int J Biochem Cell Biol; 2011 Oct; 43(10):1483-9. PubMed ID: 21726661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion flow rate substantially contributes to the performance of the HepaRG-AMC-bioartificial liver.
    Nibourg GA; Boer JD; van der Hoeven TV; Ackermans MT; van Gulik TM; Chamuleau RA; Hoekstra R
    Biotechnol Bioeng; 2012 Dec; 109(12):3182-8. PubMed ID: 22729831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HepaRG microencapsulated spheroids in DMSO-free culture: novel culturing approaches for enhanced xenobiotic and biosynthetic metabolism.
    Rebelo SP; Costa R; Estrada M; Shevchenko V; Brito C; Alves PM
    Arch Toxicol; 2015 Aug; 89(8):1347-58. PubMed ID: 25107451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaling-up of a HepaRG progenitor cell based bioartificial liver: optimization for clinical application and transport.
    van Wenum M; Treskes P; Tang CY; Coppens EJ; Jansen K; Hendriks EJ; Camus S; van Gulik TM; Chamuleau RAFM; Hoekstra R
    Biofabrication; 2017 Jun; 9(3):035001. PubMed ID: 28664876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the constitutive androstane receptor and shaken 3D-culturing increase biotransformation and oxidative phosphorylation and sensitivity to mitochondrial amiodarone toxicity of HepaRG cells.
    van der Mark VA; Adam AAA; Chang JC; Oude Elferink RP; Chamuleau RAFM; Hoekstra R
    Toxicol Appl Pharmacol; 2020 Jul; 399():115055. PubMed ID: 32428594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A practice-changing culture method relying on shaking substantially increases mitochondrial energy metabolism and functionality of human liver cell lines.
    Adam AAA; van der Mark VA; Donkers JM; Wildenberg ME; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
    PLoS One; 2018; 13(4):e0193664. PubMed ID: 29672606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs.
    Weng J; Han X; Zeng F; Zhang Y; Feng L; Cai L; Liang K; Liu S; Li S; Fu G; Zeng M; Gao Y
    Theranostics; 2021; 11(16):7620-7639. PubMed ID: 34335954
    [No Abstract]   [Full Text] [Related]  

  • 15. AMC-Bio-Artificial Liver culturing enhances mitochondrial biogenesis in human liver cell lines: The role of oxygen, medium perfusion and 3D configuration.
    Adam AAA; van Wenum M; van der Mark VA; Jongejan A; Moerland PD; Houtkooper RH; Wanders RJA; Oude Elferink RP; Chamuleau RAFM; Hoekstra R
    Mitochondrion; 2018 Mar; 39():30-42. PubMed ID: 28844938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver support therapy: an overview of the AMC-bioartificial liver research.
    van de Kerkhove MP; Poyck PP; Deurholt T; Hoekstra R; Chamuleau RA; van Gulik TM
    Dig Surg; 2005; 22(4):254-64. PubMed ID: 16174982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DMSO-free hepatocyte maturation medium accelerates hepatic differentiation of HepaRG cells in vitro.
    Wang ZY; Li WJ; Li QG; Jing HS; Yuan TJ; Fu GB; Tang D; Zhang HD; Yan HX; Zhai B
    Biomed Pharmacother; 2019 Aug; 116():109010. PubMed ID: 31136950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver.
    Poyck PP; Hoekstra R; van Wijk AC; Attanasio C; Calise F; Chamuleau RA; van Gulik TM
    Liver Transpl; 2007 Apr; 13(4):589-98. PubMed ID: 17394165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats.
    Shinoda M; Tilles AW; Kobayashi N; Wakabayashi G; Takayanagi A; Totsugawa T; Harada H; Obara H; Suganuma K; Berthiaume F; Shimazu M; Shimizu N; Tanaka N; Kitajima M; Tompkins RG; Toner M; Yarmush ML
    J Surg Res; 2007 Jan; 137(1):130-40. PubMed ID: 17081566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HepaRG Self-Assembled Spheroids in Alginate Beads Meet the Clinical Needs for Bioartificial Liver.
    Pasqua M; Pereira U; Messina A; de Lartigue C; Vigneron P; Dubart-Kupperschmitt A; Legallais C
    Tissue Eng Part A; 2020 Jun; 26(11-12):613-622. PubMed ID: 31914890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.